• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

备解素在补体激活替代途径中的作用。

The role of properdin in the alternate pathway of complement activation.

作者信息

Götze O, Müller-Eberhard H J

出版信息

J Exp Med. 1974 Jan 1;139(1):44-57. doi: 10.1084/jem.139.1.44.

DOI:10.1084/jem.139.1.44
PMID:4808709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2139515/
Abstract

Properdin (P), a highly basic euglobulin, was purified from human serum to molecular homogeneity without the use of zymosan. Isolated P was found to efficiently initiate activation of the alternate pathway of complement activation (C3 activator or properdin system) and to be an essential component during its early reaction stages. The activity of isolated P did not require the presence of an activating polysaccharide. It was therefore concluded that purified P had been obtained in an activated form (P). In an isolated reaction system containing purified C3, C3 proactivator (C3PA), and C3 proactivator convertase (C3PAse), P was able to mediate the activation of C3PAse which in turn activated C3PA to cleave C3. This activation of C3PAse was found to depend on the presence of native C3. These results allowed the formulation of a concept in which P is envisaged to act as a modulator of native C3 enabling it to activate C3PAse. Activation of C3 was efficiently mediated by P in the fluid phase. Efficient activation of C5, however, required the participation of an insoluble polysaccharide (zymosan). The possibility is raised therefore that P might also be an integral part of the multimolecular C5 convertase of the alternate pathway of complement activation.

摘要

备解素(P)是一种高度碱性的优球蛋白,在不使用酵母聚糖的情况下从人血清中纯化至分子均一性。发现分离出的P能有效启动补体激活替代途径(C3激活剂或备解素系统)的激活,并且是其早期反应阶段的必需成分。分离出的P的活性不需要存在激活多糖。因此得出结论,已获得以活化形式(P)存在的纯化的P。在含有纯化的C3、C3前激活剂(C3PA)和C3前激活剂转化酶(C3PAse)的分离反应系统中,P能够介导C3PAse的激活,而C3PAse又激活C3PA以裂解C3。发现C3PAse的这种激活取决于天然C3的存在。这些结果使得能够形成一个概念,即设想P作为天然C3的调节剂,使其能够激活C3PAse。在液相中,P有效地介导了C3的激活。然而,C5的有效激活需要不溶性多糖(酵母聚糖)的参与。因此提出了一种可能性,即P也可能是补体激活替代途径的多分子C5转化酶的一个组成部分。

相似文献

1
The role of properdin in the alternate pathway of complement activation.备解素在补体激活替代途径中的作用。
J Exp Med. 1974 Jan 1;139(1):44-57. doi: 10.1084/jem.139.1.44.
2
Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.酵母聚糖和活化备解素与缺乏D因子的豚鼠血清的相互作用:对通过替代补体途径初始C3裂解机制的影响。
Z Immunitatsforsch Immunobiol. 1977 Feb;152(5):402-14.
3
A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.慢性低补体血症性肾炎中的一种血清因子,不同于免疫球蛋白,可激活补体替代途径。
J Exp Med. 1974 May 1;139(5):1249-61. doi: 10.1084/jem.139.5.1249.
4
C3 proactivator convertase and its mode of action.C3 前活化剂转化酶及其作用方式。
J Exp Med. 1972 Apr 1;135(4):1003-8. doi: 10.1084/jem.135.4.1003.
5
Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.补体替代途径:不稳定的C3/C5转化酶招募前体备解素并增强该途径。
J Exp Med. 1976 Oct 1;144(4):1076-93. doi: 10.1084/jem.144.4.1076.
6
Changes in the immunochemical properties of highly purified properdin in human serum.人血清中高度纯化备解素免疫化学性质的变化。
J Immunol. 1975 Apr;114(4):1415-21.
7
Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.通过规避内源性控制蛋白的调节作用,利用兔红细胞激活替代补体途径。
J Exp Med. 1977 Jul 1;146(1):22-33. doi: 10.1084/jem.146.1.22.
8
Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.补体替代途径:起始因子的证实与特性及其不依赖备解素的功能
J Exp Med. 1976 Oct 1;144(4):1062-75. doi: 10.1084/jem.144.4.1062.
9
Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.备解素和肾炎因子依赖性C3转化酶:酶形成对天然C3的需求以及结合的C3b作为备解素受体的功能
J Exp Med. 1975 Sep 1;142(3):760-72. doi: 10.1084/jem.142.3.760.
10
Isolation and characterization of Guinea pig properidin.豚鼠备解素的分离与鉴定
J Immunol. 1977 Jan;118(1):103-8.

引用本文的文献

1
PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.聚乙二醇化模型药物载体增强了原代人中性粒细胞的吞噬作用。
Acta Biomater. 2018 Oct 1;79:283-293. doi: 10.1016/j.actbio.2018.09.001. Epub 2018 Sep 6.
2
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?备解素途径:C3 和 C5 激活的“替代激活途径”还是“关键扩增环”?
Semin Immunopathol. 2018 Jan;40(1):15-35. doi: 10.1007/s00281-017-0661-x. Epub 2017 Nov 22.
3
C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.C5抑制可预防致死性C3肾小球病小鼠模型中的肾衰竭。
Kidney Int. 2017 Jun;91(6):1386-1397. doi: 10.1016/j.kint.2016.11.018. Epub 2017 Jan 27.
4
Differential expression of long non-coding RNAs in three genetic lines of rainbow trout in response to infection with Flavobacterium psychrophilum.虹鳟三个遗传品系中长链非编码RNA在嗜冷黄杆菌感染后的差异表达
Sci Rep. 2016 Oct 27;6:36032. doi: 10.1038/srep36032.
5
Properdin in complement activation and tissue injury.补体激活与组织损伤中的备解素。
Mol Immunol. 2013 Dec 15;56(3):191-8. doi: 10.1016/j.molimm.2013.06.002. Epub 2013 Jun 29.
6
Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3.一种激活替代补体途径并允许同源补体C3沉积的人类膜蛋白的纯化与鉴定。
J Exp Med. 1995 Jan 1;181(1):115-25. doi: 10.1084/jem.181.1.115.
7
Solubilization of immune precipitates by six isolated alternative pathway proteins.六种分离出的替代途径蛋白对免疫沉淀物的溶解作用。
J Exp Med. 1981 Dec 1;154(6):1743-51. doi: 10.1084/jem.154.6.1743.
8
Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.免疫复合物疾病的病理生理学方面。第二部分。吞噬作用、胞吐作用和致病性沉积。
Klin Wochenschr. 1980 Jun 16;58(12):593-605. doi: 10.1007/BF01477835.
9
Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.一种用于定量检测人血清中替代补体途径激活的酶联免疫吸附测定法的开发与应用。
J Clin Invest. 1984 Jan;73(1):160-70. doi: 10.1172/JCI111187.
10
Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.C反应蛋白与补体系统的相互作用。I. 精蛋白诱导急性期血清中补体的消耗。
J Exp Med. 1974 Sep 1;140(3):631-47. doi: 10.1084/jem.140.3.631.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
The properdin system and immunity. XII. Assay, properties and partial purification of a hydrazine-sensitive serum factor (factor A) in the properdin system.备解素系统与免疫。十二。备解素系统中对肼敏感的血清因子(因子A)的测定、性质及部分纯化
Z Immun exp ther. 1959 Oct-Nov;118:329-48.
3
The properdin system and immunity. X. Characterization of partially purified human properdin.备解素系统与免疫。X. 部分纯化的人备解素的特性
J Immunol. 1959 Oct;83:428-36.
4
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
5
The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.备解素系统与免疫。十三。备解素系统中一种热不稳定血清因子(B因子)的测定及特性
Z Immun exp ther. 1959 Oct-Nov;118:349-57.
6
The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.备解素系统与免疫。IV. 阵发性夜间血红蛋白尿患者红细胞的溶血作用
J Clin Invest. 1956 May;35(5):453-7. doi: 10.1172/JCI103296.
7
The properdin system and immunity. III. The zymosan assay of properdin.备解素系统与免疫。III. 备解素的酵母聚糖测定法。
J Exp Med. 1956 Jan 1;103(1):1-13. doi: 10.1084/jem.103.1.1.
8
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.备解素系统与免疫。I. 一种新的血清蛋白——备解素的证实、分离及其在免疫现象中的作用。
Science. 1954 Aug 20;120(3112):279-85. doi: 10.1126/science.120.3112.279.
9
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.分离出含有过敏毒素和趋化活性的人补体第三成分的一个片段(C3a),并描述一种人血清过敏毒素灭活剂。
J Exp Med. 1969 May 1;129(5):1109-30. doi: 10.1084/jem.129.5.1109.
10
The reaction mechanism of human C5 in immune hemolysis.人补体C5在免疫溶血中的反应机制。
J Exp Med. 1970 Oct 1;132(4):775-93. doi: 10.1084/jem.132.4.775.